CASE DISCUSSION

Autism and Neurological Interventions

Presented from India by Dr. Indrashish Ray Chaudhuri

Likes

3363

Views

135

101

Bookmarks

Case Description

Autism Spectrum Disorder (ASD) often involves complex neurological challenges that affect communication, behavior, and social interactions. Neurological interventions, such as neurofeedback, sensory integration therapy, and transcranial magnetic stimulation, are emerging as potential tools to...

Case Summary

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition often overlooked, leading to delayed interventions. Early detection is crucial for better outcomes, and pediatric neurologists, child psychiatrists, and therapists play a vital role. The DSM-5 criteria provides a framework for diagnosis, and recognizing red flag signs before age one is essential for early intervention.

Speaker Profile

Dr. Indrashish Ray Chaudhuri

Pediatric Neurologist, Amrita Institute of Medical Sciences, Kochi

Dr. Indrashish Ray Chaudhuri, a Pediatric Neurologist at Amrita Institute of Medical Sciences (AIMS), Kochi, is a distinguished medical professional and gold medalist from NRS Medical College, Kolkata. He earned his MD in Pediatrics from University College of Medical Sciences, Delhi, and completed his MRCPCH (UK) in Pediatrics in 2022. Dr. Chaudhuri specializes in challenging neurological conditions, including difficult-to-treat epilepsies, neurometabolic disorders, dietary therapies for epilepsy, and autoimmune neurological diseases. He has several publications and is an active member of the Indian Academy of Neurology, the International League Against Epilepsy (Young Epilepsy Section), and the LGS Foundation. Recently, he was honored with the International Child Neurology Association's Best Paper in Epilepsy award at the International Child Neurology Congress in Cape Town, South Africa.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.